,drug_name,drug_type,Smiles
0,Aminogluthetimide,19A-Inhibitor,CC[C@]1(CCC(=O)NC1=O)C2=CC=C(N)C=C2
1,Anastrozole,19A-Inhibitor,CC(C)(C#N)C1=CC(CN2C=NC=N2)=CC(=C1)C(C)(C)C#N
2,Androstanolone,19A-Substrate,C[C@]12CC[C@H]3[C@@H](CC[C@H]4CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2O
3,Betamethason,19A-Inducer,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
4,Betamethason,19A-Substrate,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
5,Bifonazole,19A-Inhibitor,C1=CC=C(C=C1)[C@H](N2C=CN=C2)C3=CC=C(C=C3)C4=CC=CC=C4
6,Bucladesine,19A-Inducer,CCCC(=O)NC1=C2N=CN([C@@H]3O[C@@H]4CO[P@](O)(=O)O[C@H]4[C@H]3OC(=O)CCC)C2=NC=N1
7,Buserelin,19A-Inducer,CCNC(=O)[C@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](COC(C)(C)C)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)[C@H](CO)NC(=O)[C@H](CC3=CNC4=CC=CC=C34)NC(=O)[C@H](CC5=CNC=N5)NC(=O)[C@H]6CCC(=O)N6
8,Clofenotane,19A-Inhibitor,ClC1=CC=C(C=C1)C(C2=CC=C(Cl)C=C2)C(Cl)(Cl)Cl
9,Clomifene,19A-Inhibitor,CCN(CC)CCOC1=CC=C(C=C1)C(=C(/Cl)C2=CC=CC=C2)C3=CC=CC=C3
10,Clonidine,19A-Inducer,ClC1=CC=CC(Cl)=C1NC2=NCCN2
11,Clotrimazole,19A-Inhibitor,ClC1=C(C=CC=C1)C(N2C=CN=C2)(C3=CC=CC=C3)C4=CC=CC=C4
12,Cyproterone,19A-Inhibitor,CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@]12C
13,Danazol,19A-Inhibitor,C[C@]12CC3=C(ON=C3)C=C1CC[C@@H]4[C@@H]2CC[C@@]5(C)[C@H]4CC[C@@]5(O)C#C
14,Dibutylphthalate,19A-Inducer,CCCCOC(=O)C1=C(C=CC=C1)C(=O)OCCCC
15,Diethylstilbestrol,19A-Inducer,CCC(C1=CC=C(O)C=C1)=C(CC)C2=CC=C(O)C=C2
16,Dinoprostone,19A-Inducer,CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O
17,Dopamine,19A-Inhibitor,NCCC1=CC(O)=C(O)C=C1
18,Econazole,19A-Inhibitor,ClC1=CC=C(CO[C@@H](C[C@H]2C=NC=N2)C3=C(Cl)C=C(Cl)C=C3)C=C1
19,Ethanol,19A-Inducer,CCO
20,Etomidate,19A-Inhibitor,CCOC(=O)C1=CN=CN1[C@@H](C)C2=CC=CC=C2
21,Etretinate,19A-Inhibitor,CCOC(=O)C=C(C)C=CC=C(C)C=CC1=C(C)C(C)=C(OC)C=C1C
22,Exemestane,19A-Inhibitor,C[C@]12CC[C@H]3[C@@H](CC(=C)C4=CC(=O)C=C[C@]34C)[C@@H]1CCC2=O
23,Fluconazole,19A-Inhibitor,OC(CN1C=NC=N1)(CN2C=NC=N2)C3=C(F)C=C(F)C=C3
24,Formestane,19A-Inhibitor,C[C@]12CC[C@H]3[C@@H](CCC4=C(O)C(=O)CC[C@]34C)[C@@H]1CCC2=O
25,Glutathione,19A-Inducer,N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O
26,Insulin (human),19A-Inducer,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CN=CN3)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC4=CC=CC=C4)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC5=CN=CN5)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC6=CC=C(O)C=C6)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC7=CC=C(O)C=C7)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC8=CC=C(O)C=C8)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC9=CC=CC=C9)C(=O)N[C@@H](CC%10=CC=CC=C%10)C(=O)N[C@@H](CC%11=CC=C(O)C=C%11)C(=O)N[C@@H]([C@@H](C)O)C(=O)N%12CCC[C@H]%12C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)NC1=O)[C@@H](C)O)[C@@H](C)CC
27,Isoconazole,19A-Inhibitor,ClC1=CC(Cl)=C(C=C1)[C@H](CN2C=CN=C2)OCC3=C(Cl)C=CC=C3Cl
28,Isoprenaline,19A-Inducer,CC(C)NC[C@H](O)C1=CC(O)=C(O)C=C1
29,Itraconazole,19A-Inhibitor,CC[C@H](C)N1N=CN(C1=O)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(OC[C@H]5CO[C@@](CN6C=NC=N6)(O5)C7=C(Cl)C=C(Cl)C=C7)C=C4
30,Letrozole,19A-Inhibitor,N#CC1=CC=C(C=C1)C(N2C=NC=N2)C3=CC=C(C=C3)C#N
31,Letrozole,19A-Substrate,N#CC1=CC=C(C=C1)C(N2C=NC=N2)C3=CC=C(C=C3)C#N
32,Levacetylmethadol,19A-Substrate,CC[C@H](OC(C)=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
33,Levonorgestrel,19A-Inhibitor,CC[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C
34,Mefloquine,19A-Inhibitor,O[C@H]([C@H]1CCCCN1)C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F
35,Melatonin,19A-Inhibitor,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1
36,Methadone,19A-Substrate,CCC(=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
37,Methyltestosterone,19A-Inducer,[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
38,Miconazole,19A-Inhibitor,ClC1=CC=C(CO[C@H](CN2C=CN=C2)C3=CC=C(Cl)C=C3Cl)C(Cl)=C1
39,Nandrolone,19A-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@H]2O
40,Norepinephrine,19A-Inhibitor,NC[C@@H](O)C1=CC(O)=C(O)C=C1
41,Oxycodone,19A-Inhibitor,COC1=CC=C2C[C@H]3N(C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O
42,Paclitaxel,19A-Inhibitor,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C6=CC=CC=C6)C7=CC=CC=C7)C(C)=C1C5(C)C
43,Phenylephrine,19A-Inducer,CNC[C@H](O)C1=CC(O)=CC=C1
44,Prasterone,19A-Substrate,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@]34C)[C@@H]1CCC2=O
45,Raloxifene,19A-Inhibitor,OC1=CC=C(C=C1)C2=C(C(=O)C3=CC=C(OCCN4CCCCC4)C=C3)C5=CC=C(O)C=C5S2
46,Tamoxifen,19A-Inhibitor,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
47,Terbinafine,19A-Inhibitor,CN(CC=CC#CC(C)(C)C)CC1=C2C=CC=CC2=CC=C1
48,Testosterone,19A-Substrate,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
49,Tibolone,19A-Inhibitor,C[C@@H]1CC2=C(CCC(=O)C2)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]4(O)C#C)[C@H]13
50,Tinidazole,19A-Inhibitor,CCS(=O)(=O)CCN1C(C)=NC=C1[N+]([O-])=O
51,Tioconazole,19A-Inhibitor,ClC1=CC(Cl)=C(C=C1)[C@@H](CN2C=CN=C2)OCC3=C(Cl)SC=C3
52,Trastuzumab,19A-Inhibitor,NCC=C
53,Troglitazone,19A-Inhibitor,CC1=C(C)C2=C(CC[C@](C)(COC3=CC=C(C[C@@H]4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
54,Vorozole,19A-Inhibitor,CN1N=NC2=C1C=C(C=C2)[C@@H](N3C=NC=N3)C4=CC=C(Cl)C=C4
